©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 112675
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112675
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112675
Table 2 Summary of hepatocellular carcinoma prediction models based on serum biomarkers
| Model name | Components/equation | Ref. |
| GALAD | -10.08 + 0.09 × age + 1.67 × gender + 0.04 × AFP-L3% + 2.34 × log10 AFP + 1.33 × log10 DCP | Johnson et al[88], 2014 |
| GAAP | 9.134 + 0.892 × gender + 0.073 × age + 1.057 × log10 AFP + 1.015 × log10 DCP | Liu et al[89], 2020 |
| AALP | 7.245 + 0.056 × age + 0.431 × log10 AFP + 3.112 × AFP-L3 + 1.162 × log10 PIVKA-II | Ren et al[90], 2023 |
| ASAP | -7.577 + 0.047 × age - 0.576 × gender + 0.422 × lnAFP + 1.105 × lnDCP | Sun et al[91], 2025 |
| GAAD | Gender, age, PIVKA-II, AFP | Piratvisuth et al[92], 2023 |
| GAADPB | 0.176 + 0.162 × gender + 0.002 × age + 0.178 × log10 AFP + 0.164 × log10 DCP - 0.007 × TP - 0.002 × TB | Chen et al[93], 2023 |
| BALAD | Bilirubin, albumin, AFP-L3, AFP, DCP | Toyoda et al[94], 2006 |
| BALAD-2 | 0.02 × (AFP-2.57) + 0.012 × (AFP-L3 - 14.19) + 0.19 × (lnDCP - 1.93) + 0.17 × (Bilirubin1/2 - 4.5) - 0.09 × (albumin - 35.11) | Fox et al[95], 2014 |
| Doylestown | 1/{1 + exp[-(-10.307 + 0.097 × age + 1.645 × gender + 2.315 × log10 AFP + 0.011 × ALP - 0.008 × ALT)]} | Wang et al[96], 2016 |
| Doylestown Plus | Age, logAFP, PEG-precipitated IgG, fucosylated kininogen | Singal et al[97], 2022 |
| HES V1.0 | Age, current AFP level, AFP change rate, ALT, platelets | Tayob et al[98], 2021 |
| HES V2.0 | Age, current AFP level, AFP change rate, ALT, platelets, AFP-L3, DCP | El-Serag et al[99], 2025 |
- Citation: Liu ZH, Wang WJ, Dang SS. Early screening for liver cancer must be performed. World J Hepatol 2025; 17(11): 112675
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/112675.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.112675